Authors/Disclosures
|
Ellen M. Mowry, MD, FAAN
(Johns Hopkins University)
|
Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
Amanda Mook, MD
(Cleveland Clinic)
|
No disclosure on file |
|
Jean Pelletier, MD, PhD
(Dpt of Neurology, CHU Timone)
|
Dr. Pelletier has nothing to disclose. |
|
Pierre Duquette, MD
|
The institution of Dr. Duquette has received research support from Biogen and Genzyme. |
|
Pablo Villoslada, MD, PhD, FAAN
(Hospital del Mar Research Institute)
|
Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Therapeutics. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care. |
|
Irina Malikova
(CHU Timone)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jamie C. McDonald, MD
(Stanford University)
|
Dr. McDonald has nothing to disclose. |
|
Elaine Roger
(CHUM - Hopital Notre-Dame)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jorge Oksenberg, MD
(UCSF)
|
No disclosure on file |
|
Emmanuelle Waubant, MD, PhD, FAAN
(USCF MS Center)
|
The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care. |